Claim 7 of this request for all designated Contracting States except ES and GR is an amended version of claim 24 as granted, whereby the ligand is defined as being for the B7 antigen, being a fusion protein that contains at least a portion of the extracellular domain of CTLA4 and being capable of interfering with the reaction of endogenous B7 antigen with CTLA4.